Pharsight

Drugs that contain Vancomycin Hydrochloride

1. Firvanq Kit patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10959949 AZURITY Composition and method for vancomycin oral liquid
Mar, 2035

(10 years from now)

US10959947 AZURITY Composition and method for vancomycin oral liquid
Mar, 2035

(10 years from now)

US10959948 AZURITY Composition and method for vancomycin oral liquid
Mar, 2035

(10 years from now)

US11638692 AZURITY Composition and method for vancomycin oral liquid
Mar, 2035

(10 years from now)

US10688046 AZURITY Composition and method for vancomycin oral liquid
Mar, 2035

(10 years from now)

US10959946 AZURITY Composition and method for vancomycin oral liquid
Mar, 2035

(10 years from now)

US10493028 AZURITY Composition and method for vancomycin oral liquid
Mar, 2035

(10 years from now)

Market Authorisation Date: 26 January, 2018

Treatment: Treatment of c. difficile-associated diarrhea

Dosage: FOR SOLUTION;ORAL

How can I launch a generic of FIRVANQ KIT before it's drug patent expiration?
More Information on Dosage

FIRVANQ KIT family patents

Family Patents

2. Vancomycin Hydrochloride patents expiration

VANCOMYCIN HYDROCHLORIDE's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10188697 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(11 years from now)

US10039804 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(11 years from now)

US10849956 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(11 years from now)

US11628200 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(11 years from now)

US11517609 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(11 years from now)

Market Authorisation Date: 15 February, 2019

Treatment: Method of treating bacterial infections

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

VANCOMYCIN HYDROCHLORIDE family patents

Family Patents